ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $229,000 | -9.5% | 5,439 | -1.5% | 0.00% | -20.0% |
| Q3 2020 | $253,000 | -10.6% | 5,524 | -1.8% | 0.01% | -16.7% |
| Q2 2020 | $283,000 | -3.4% | 5,627 | -1.1% | 0.01% | -14.3% |
| Q1 2020 | $293,000 | -20.4% | 5,688 | -4.6% | 0.01% | +16.7% |
| Q4 2019 | $368,000 | +1.4% | 5,962 | -1.3% | 0.01% | -14.3% |
| Q3 2019 | $363,000 | -30.3% | 6,041 | -2.1% | 0.01% | -22.2% |
| Q2 2019 | $521,000 | +36.7% | 6,171 | +54.7% | 0.01% | +28.6% |
| Q1 2019 | $381,000 | – | 3,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |